Casirivimab and Imdevimab Combination Provides Long-Term
Protection Against COVID-19 - phase 3 study in preventing
COVID in household contacts of infected individuals
CROI 2022 Feb 11-16
Meagan P. O'Brien, MD
Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA
On behalf of the Regeneron and CoVPN/NIAID COVID-19
Phase 3 Prevention Trial Team
